Minimal change disease related to rifampicin presenting with acute renal failure during treatment for latent tuberculosis infection: A case report

RATIONALE: The standard drugs used to treat tuberculosis are rifampicin and isoniazid. These agents are usually safe and inexpensive for short-term use in treatment of latent tuberculosis infection, but sometimes cause adverse renal effects, including minimal change disease (MCD). PATIENT CONCERNS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jee-Seon, Kim, Kyong-Ju, Choi, Eun-Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392561/
https://www.ncbi.nlm.nih.gov/pubmed/29851774
http://dx.doi.org/10.1097/MD.0000000000010556

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392561/
https://www.ncbi.nlm.nih.gov/pubmed/29851774
http://dx.doi.org/10.1097/MD.0000000000010556

Ejemplares similares